CDC BMI Trajectories Analysis in PEDSnet

PEDSnet fulfilled a feasibility query in 2017 submitted by the CDC to assess availability of data to describe BMI trajectories of children. A major impetus for the request is a dearth of longitudinal BMI data that is current. The CDC has identified the following aims for an analysis it would like to publish, and is interested in co-authoring the manuscript with PEDSnet. Specific aims included 1) To describe patterns of longitudinal tracking of BMI over time, including methodology related to longitudinal correlation coefficients, biologically implausible values. 2) To describe trends and disparities in weight status (healthy weight, overweight, obese and severely obese) annually and overall. The CDC is requesting a dataset including the following data elements: Age in months at encounter, Sex, Race, Ethnicity, Height, Weight, Chronic condition indicator [as defined by the Pediatric Medical Complexity Algorithm (PMCA)], Private/public coverage indicator

Clinical Outcomes by Language of Care in Pediatric Oncology

Although language disparities in outcomes are well documented in general pediatrics and adult oncology, little is known in pediatric oncology. Patient or family language is not included in many multi- institutional databases and patient registries, limiting studies of language-based inequities…

Extreme weather impacts on children’s acute and chronic health outcomes; a multisite study with evaluation of vulnerabilities

The “Extreme Weather and Pediatric Health Outcomes” study investigates the impact of climate change-related extreme weather events, such as extreme heat and heavy rainfall, on children’s health across the United States. This innovative research aims to address critical knowledge gaps…

Characterization of Babies Born with Hemolytic Disease of the Fetus/Newborn (HDFN)

Hemolytic disease of the fetus and newborn (HDFN) otherwise known as erythroblastosis fetalis, is a disease in which fetal and neonatal erythrocytes are destroyed by maternal IgG alloantibodies. Before the first RhD immunoprophylaxis was introduced as a treatment in 1968,…

Scroll to Top